Blog

Replacing part of one’s usual diet with a soy-based meal replacement powder for 12 weeks did not significantly alter gut microbiome diversity or reduce …

For the roughly one in three IBS patients with constipation-predominant (IBS-C) symptoms, effective management often requires moving beyond simple laxat…

A specific bacterium residing in the gut, Akkermansia muciniphila , is emerging as a central player in metabolic health

Pathophysiology-Driven Natural Approaches for IBS-C Management Irritable Bowel Syndrome with constipation (IBS-C) involves more than infrequent bowel mo…

Beyond Fiber: A Pathophysiology-Driven Approach to Managing IBS-C Irritable Bowel Syndrome with constipation (IBS-C) is more than slow transit; it’s a d…

Irritable bowel syndrome with constipation (IBS-C) is a complex disorder where chronic abdominal pain and bloating accompany difficult, infrequent bowel…

Introduction A complex axis linking the gut microbiome, immune function, and metabolic health is emerging as a fundamental factor in conditions ranging …

Introduction Irritable bowel syndrome with constipation (IBS-C) involves more than infrequent bowel movements

Irritable bowel syndrome with constipation (IBS-C) is not simply a slow-moving gut

Beyond Fiber: A Pathophysiology-Driven Approach to IBS-C Treatment Irritable bowel syndrome with constipation (IBS-C) is more than a motility problem

Irritable bowel syndrome with constipation (IBS-C) is a complex disorder where abdominal pain and infrequent bowel movements stem from multiple interact…

Beyond Linaclotide: New Evidence on IBS-C Relief via Gut-Brain Axis Irritable Bowel Syndrome with constipation (IBS-C) is a complex, multifactorial diso…